Published in Clin Pharmacol Ther on December 27, 2006
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther (2007) 2.54
Warfarin pharmacogenetics. Pharmacotherapy (2008) 2.50
Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Pharmacogenomics (2008) 1.89
VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans. Pharmacogenomics (2008) 1.65
Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans. Per Med (2007) 1.26
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Blood Cells Mol Dis (2009) 1.02
Expectations, validity, and reality in pharmacogenetics. J Clin Epidemiol (2009) 0.96
Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. Eur J Clin Pharmacol (2009) 0.91
Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population. Indian J Hum Genet (2013) 0.84
VKORC1 -1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement. Eur J Clin Pharmacol (2010) 0.83
Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum. Korean J Intern Med (2014) 0.83
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice. Eur J Clin Pharmacol (2008) 0.82
Analysis of gene-gene interactions using gene-trait similarity regression. Hum Hered (2014) 0.80
Screening for 392 polymorphisms in 141 pharmacogenes. Biomed Rep (2014) 0.80
Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database. PLoS One (2015) 0.78
Pharmacogenetics of cardiovascular drug therapy. Clin Cases Miner Bone Metab (2009) 0.75
Treatment of a long-acting anticoagulant rodenticide poisoning cohort with vitamin K1 during the maintenance period. Medicine (Baltimore) (2016) 0.75
Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients. Sci Rep (2017) 0.75
Pharmacogenetic characteristics of patients with complicated phenprocoumon dosing. Eur J Clin Pharmacol (2009) 0.75
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost (2006) 3.49
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol (1997) 3.02
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev (2004) 2.19
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers. Circulation (1992) 2.10
Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol (2004) 2.03
Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses. J Thromb Haemost (2013) 1.98
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart (2004) 1.69
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol (1999) 1.69
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit (2002) 1.60
A cytochrome b5 is required for full activity of flavonoid 3', 5'-hydroxylase, a cytochrome P450 involved in the formation of blue flower colors. Proc Natl Acad Sci U S A (1999) 1.54
Simpson's paradox: an example from hospital epidemiology. Epidemiology (2000) 1.51
Women with angina pectoris receive less antiplatelet treatment than men. Br J Gen Pract (1999) 1.51
Reproducibility of childhood respiratory symptom questions. Eur Respir J (1992) 1.49
Effect of evacuated blood collection tubes on thromboplastin calibration. Thromb Haemost (1998) 1.43
Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther (2008) 1.42
Pharmacogenetics: from bench to byte. Clin Pharmacol Ther (2008) 1.40
[Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism]. Ned Tijdschr Geneeskd (2006) 1.39
Ruptured abdominal aortic aneurysms: factors influencing postoperative mortality and long-term survival. Eur J Vasc Endovasc Surg (1998) 1.39
[Hypersexuality during use of levodopa]. Ned Tijdschr Geneeskd (2002) 1.38
Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology (2006) 1.34
Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol (2003) 1.33
Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost (2004) 1.26
Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord (2006) 1.25
Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol (2004) 1.22
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf (2001) 1.21
Risk factors for the development of lithium-induced polyuria. Br J Psychiatry (2003) 1.19
Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia (2013) 1.18
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res (1994) 1.18
Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol (2001) 1.17
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17
Thalidomide as treatment for digestive tract angiodysplasias. Neth J Med (2006) 1.16
Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med (2003) 1.13
Long term persistence with statin treatment in daily medical practice. Heart (2004) 1.13
The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin Exp Rheumatol (1993) 1.13
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol (2002) 1.12
Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol (2000) 1.12
Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke (2000) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int (2009) 1.08
Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther (2004) 1.07
Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth (2002) 1.07
Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest (1997) 1.06
Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol (1993) 1.05
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care (2009) 1.03
Interpretation and inference in noninferiority randomized controlled trials in drug research. Clin Pharmacol Ther (2010) 1.02
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2009) 1.02
Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX. J Thromb Haemost (2004) 1.01
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost (1986) 1.00
Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med (2003) 0.98
Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol (2003) 0.98
Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol (2008) 0.98
Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol (2002) 0.97
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. Br J Cancer (2010) 0.96
Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clin Pharmacokinet (2012) 0.95
[Effect of gastric banding on pharmacotherapy: not much known]. Ned Tijdschr Geneeskd (2007) 0.95
Quality improvement of oral medication administration in patients with enteral feeding tubes. Qual Saf Health Care (2006) 0.94
Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain (1998) 0.93
Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf (2002) 0.93
Selection of oncology medicines in low- and middle-income countries. Ann Oncol (2014) 0.93
Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. Eur J Clin Pharmacol (2007) 0.92
Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users. Int J Impot Res (2002) 0.91
Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis (2003) 0.91
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Thromb Haemost (2001) 0.89
Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999. Pharmacoepidemiol Drug Saf (2002) 0.89
Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology (Berl) (2010) 0.89
Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens (2004) 0.89
Within-patient variability of myogenic motor-evoked potentials to multipulse transcranial electrical stimulation during two levels of partial neuromuscular blockade in aortic surgery. Anesth Analg (1999) 0.89
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol (2014) 0.89
Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens (1998) 0.89
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs. J Thromb Haemost (2011) 0.88
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol (2002) 0.88
Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems? Br J Clin Pharmacol (2002) 0.88
Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation (2012) 0.88
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease. Pharm World Sci (2001) 0.87
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther (2001) 0.87
Risk of fracture in patients with Parkinson's disease. Osteoporos Int (2013) 0.87
Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients. J Clin Pharm Ther (2013) 0.87
Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens (1998) 0.87
Incidence and determinants of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol (2002) 0.86
Determinants of DNA yield and purity collected with buccal cell samples. Eur J Epidemiol (2009) 0.86
Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost (2004) 0.86
Pathogenic potential and horizontal gene transfer in ovine gastrointestinal Escherichia coli. J Appl Microbiol (2009) 0.86
Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int (2010) 0.86
Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice. Eur J Clin Pharmacol (2004) 0.86
The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary (2010) 0.86
Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens (2008) 0.86
Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology (2006) 0.86